| Bioactivity | Dechloro Rivaroxaban is a highly selective, orally active inhibitor of Factor Xa. Dechloro Rivaroxaban inhibits human free FXa with a Ki of 0.4 nM. Dechloro Rivaroxaban inhibits prothrombinase activity and fibrin-associated FXa activity with IC50s of 2.1 nM and 92 nM, respectively[1]. | ||||||||||||
| Name | Dechloro Rivaroxaban | ||||||||||||
| CAS | 1415566-28-7 | ||||||||||||
| Formula | C19H19N3O5S | ||||||||||||
| Molar Mass | 401.44 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Lang D, et al. In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans. Drug Metab Dispos. 2009 May;37(5):1046-55. |
Dechloro Rivaroxaban
CAS: 1415566-28-7 F: C19H19N3O5S W: 401.44
Dechloro Rivaroxaban is a highly selective, orally active inhibitor of Factor Xa. Dechloro Rivaroxaban inhibits human fr
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.